October 9, 2018
Hemostemix (TSXV:HEM) is pleased to announce that it has received all approvals from three new medical centers to be clinical trial...
April 29, 2018
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 25, 2018
Pluristem Therapeutics (Nasdaq:PSTI) a leading developer of placenta-based cell therapy products, announced today that the U.S. Food and Drug Administration (FDA)...
April 19, 2018
The cell-therapy company's share price increased by over 90 percent after the milestone announcement was released on Thursday.
April 17, 2018
Biomerica (Nasdaq:BMRA) today reported net sales of $4,433,785 for the nine months ending February 28, 2018, compared to $4,342,247 for...
April 6, 2018
EyeGate Pharmaceuticals (NASDAQ:EYEG) announced completion of patient enrollment for the pivotal Phase 3 clinical study of its EGP-437 combination product...
April 1, 2018
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.